Where hospitality meets science to improve clinical trial management. Clincierge enables patients to connect more effectively with clinical trials of new medicines. We reduce barriers to trial participation making it possible for patients and others to gain faster access to potentially useful new treatments. Our unique services - including individualized travel and housing logistics, payment/reimbursement systems and on-going patient, family and caregiver support - reduce the anxiety and out-of-pocket expense that patients and their families too often face when participating in clinical trials. We address special patient needs and the demands that complex trial designs place on them and their families, building custom solutions to specific study-related problems as required. From the time a patient enrolls in a Clincierge-supported study until its completion, our multi-lingual, in-country clincierges provide seamless, personalized support for patients, their families and caregivers, communicating closely with them each step of the way. By helping patients, we help trial sponsors, CROs and research institutions manage the cost and time of clinical trials. Clincierge's value-added services not only enhance patient recruitment and improve retention, they also relieve clinical research associates, clinical investigators and other study sponsor and trial site personnel from time-consuming patient logistics, enabling them to focus on patient care and the study itself. We reduce trial administrative costs and increase the timeliness of payments by managing such financial details via our efficient online payment platform.

MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies.